Oesophageal Cancer clinical trials

Explore recruiting oesophageal cancer clinical trials.

Recruiting oesophageal cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oesophageal Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Nivolumab during active surveillance after neoadjuvant chemoradiation for esophageal cancer: SANO-3 study

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Add-Aspirin: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non metastatic solid tumours.

Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

ARION : Association of Radiochemotherapy and Immunotherapy for the treatment of unresectable Oesophageal caNcer: a comparative randomized phase II trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Total Neoadjuvant Therapy for lymph node-positive adenocarcinoma of the OESophagus and oesophagogastric junction: TNT-OES-2 trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

INTEGRATE IIb A Randomised Phase III Open Label Study of regorafenib + nivolumab vs standard chemotherapy in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Austria, Germany, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I study to evaluate the safety and dosimetry of 68Ga-labelled OncoFAP derivatives in patients with solid tumors

Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Oesophageal Cancer trials by city

Oesophageal Cancer in Toronto Oesophageal Cancer in Vancouver Oesophageal Cancer in Montreal Oesophageal Cancer in Calgary Oesophageal Cancer in Edmonton Oesophageal Cancer in Ottawa Oesophageal Cancer in Winnipeg Oesophageal Cancer in Quebec City Oesophageal Cancer in Hamilton Oesophageal Cancer in Kitchener Oesophageal Cancer in London Oesophageal Cancer in Halifax Oesophageal Cancer in New York Oesophageal Cancer in Los Angeles Oesophageal Cancer in Chicago Oesophageal Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease